Calm down, Ocugen is just a biotech company in the research stage.

2021-09-14

$Histogenics(OCGN)$ While the WHO development is good news, keep in mind that Ocugen is a research-stage biotech with no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":886573862,"tweetId":"886573862","gmtCreate":1631610023853,"gmtModify":1631610023853,"author":{"id":3479274792179683,"idStr":"3479274792179683","authorId":3479274792179683,"authorIdStr":"3479274792179683","name":"lindsay877","avatar":"https://static.laohu8.com/picture138","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":24,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Calm down, Ocugen is just a biotech company in the research stage.","extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a> While the WHO development is good news, keep in mind that Ocugen is a research-stage biotech with no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a> While the WHO development is good news, keep in mind that Ocugen is a research-stage biotech with no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.</p></body></html>","text":"$Histogenics(OCGN)$ While the WHO development is good news, keep in mind that Ocugen is a research-stage biotech with no late-stage pipeline candidates, and it does not even own Covaxin. To make matters worse, the company has been seeking a Biologic License Application with the U.S. Food and Drug Administration for approval since June, which would take a very long time and also need an additional clinical trial to support the application. If that weren't enough, half of all profits from this venture would go to Bharat Biotech.","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/886573862","repostId":0,"isVote":1,"tweetType":1,"viewCount":2884,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["OCGN"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":446,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/886573862"}